Lipoatrophy associated with lispro insulin in insulin pump therapy - An old complication, a new cause?

被引：40
作者：
Griffin, ME
Feder, A
Tamborlane, WV
机构：
[1] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA
[2] W Virginia Sch Med, Wheeling, WV USA
来源：
DIABETES CARE | 2001年 / 24卷 / 01期
关键词：
D O I：
10.2337/diacare.24.1.174
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：174 / 174
页数：1
相关论文
共 4 条
[1]   Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin [J].
Fineberg, NS ;
Fineberg, SE ;
Anderson, JH ;
Birkett, MA ;
Gibson, RG ;
Hufferd, S .
DIABETES, 1996, 45 (12) :1750-1754
[2]   Severe insulin resistance in a patient with type 1 diabetes and stiff-man syndrome treated with insulin lispro [J].
Hirsch, IB ;
D'Alessio, D ;
Eng, L ;
Davis, C ;
Lernmark, Å ;
Chait, A .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 41 (03) :197-202
[3]   Lispro analog for treatment of generalized allergy to human insulin [J].
Kumar, D .
DIABETES CARE, 1997, 20 (09) :1357-1359
[4]   Severe antibody-mediated human insulin resistance: Successful treatment with the insulin analog lispro [J].
Lahtela, JT ;
Knip, M ;
Paul, R ;
Antonen, J ;
Salmi, J .
DIABETES CARE, 1997, 20 (01) :71-73
1